Section Arrow
CARM.NASDAQ
- Carisma Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2025/09/02 04:26 EDT
Pre Market
Last
 0.5048
+0.2898 (+134.79%)
Bid
0.5041
Ask
0.5049
High 0.559 
Low 0.45 
Volume 11955362 
Regular Hours
Last
 0.215
-0.013 (-5.70%)
Day High 
0.2331 
Prev. Close
0.228 
1-M High
0.364 
Volume 
91.63M 
Bid
0.5041
Ask
0.5049
Day Low
0.2106 
Open
0.229 
1-M Low
0.2102 
Market Cap 
9.53M 
Currency USD 
P/E -- 
%Yield 57.25 
10-SMA 0.24 
20-SMA 0.27 
50-SMA 0.35 
52-W High 1.27 
52-W Low 0.1417 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.19/-0.52
Enterprise Value
10.27M
Balance Sheet
Book Value Per Share
-1.10
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
19.63M
Operating Revenue Per Share
0.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CARMCarisma Therapeutics0.215-0.013-5.70%-- 
Pre Market 0.5048 +0.2898 +134.79%
TNFATNF Pharmaceuticals Inc.0.0483-0.0133-21.59%-- 
Pre Market -- -- --
ADAPAdaptimmune Therapeutics plc0.0589-0.01-14.51%-- 
Pre Market 0.061 +0.0021 +3.57%
SRPTSarepta Therapeutics18.2-0.14-0.76%15.76PE
Pre Market 18.29 +0.09 +0.49%
OTLKOutlook Therapeutics0.8512-0.2388-21.91%0.58PE
Pre Market 0.855 +0.0038 +0.45%
Quotes are at least 15-min delayed:2025/09/02 04:26 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.